226 related articles for article (PubMed ID: 27803984)
1. α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.
Kim JS; Park IS; Park HE; Kim SY; Yun JA; Jung CK; Sung HY; Lee JK; Kang WK
Neurol Sci; 2017 Jan; 38(1):171-179. PubMed ID: 27803984
[TBL] [Abstract][Full Text] [Related]
2. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
Shannon KM; Keshavarzian A; Dodiya HB; Jakate S; Kordower JH
Mov Disord; 2012 May; 27(6):716-9. PubMed ID: 22550057
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
[TBL] [Abstract][Full Text] [Related]
4. Similar α-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls.
Antunes L; Frasquilho S; Ostaszewski M; Weber J; Longhino L; Antony P; Baumuratov A; Buttini M; Shannon KM; Balling R; Diederich NJ
Mov Disord; 2016 Oct; 31(10):1567-1570. PubMed ID: 27324838
[TBL] [Abstract][Full Text] [Related]
5. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
7. Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients.
Stokholm MG; Danielsen EH; Hamilton-Dutoit SJ; Borghammer P
Ann Neurol; 2016 Jun; 79(6):940-9. PubMed ID: 27015771
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease.
Hilton D; Stephens M; Kirk L; Edwards P; Potter R; Zajicek J; Broughton E; Hagan H; Carroll C
Acta Neuropathol; 2014 Feb; 127(2):235-41. PubMed ID: 24240814
[TBL] [Abstract][Full Text] [Related]
9. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
11. Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson's disease.
Zhou J; Broe M; Huang Y; Anderson JP; Gai WP; Milward EA; Porritt M; Howells D; Hughes AJ; Wang X; Halliday GM
Acta Neuropathol; 2011 Jun; 121(6):695-704. PubMed ID: 21400129
[TBL] [Abstract][Full Text] [Related]
12. Spinal cord lesions in sporadic Parkinson's disease.
Del Tredici K; Braak H
Acta Neuropathol; 2012 Nov; 124(5):643-64. PubMed ID: 22926675
[TBL] [Abstract][Full Text] [Related]
13. Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon.
Sharrad DF; de Vries E; Brookes SJ
J Comp Neurol; 2013 Feb; 521(3):657-76. PubMed ID: 22821666
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
15. In vivo gastric detection of α-synuclein inclusions in Parkinson's disease.
Sánchez-Ferro Á; Rábano A; Catalán MJ; Rodríguez-Valcárcel FC; Fernández Díez S; Herreros-Rodríguez J; García-Cobos E; Álvarez-Santullano MM; López-Manzanares L; Mosqueira AJ; Vela Desojo L; López-Lozano JJ; López-Valdés E; Sánchez-Sánchez R; Molina-Arjona JA
Mov Disord; 2015 Apr; 30(4):517-24. PubMed ID: 25113060
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker.
Chung SJ; Kim J; Lee HJ; Ryu HS; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Lee JY; Hong SM; Myung SJ
Mov Disord; 2016 Feb; 31(2):241-9. PubMed ID: 26686342
[TBL] [Abstract][Full Text] [Related]
17. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
18. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
[TBL] [Abstract][Full Text] [Related]
19. Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.
Compta Y; Valente T; Saura J; Segura B; Iranzo Á; Serradell M; Junqué C; Tolosa E; Valldeoriola F; Muñoz E; Santamaria J; Cámara A; Fernández M; Fortea J; Buongiorno M; Molinuevo JL; Bargalló N; Martí MJ
J Neurol; 2015 Feb; 262(2):294-306. PubMed ID: 25380583
[TBL] [Abstract][Full Text] [Related]
20. The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease.
Lee JM; Derkinderen P; Kordower JH; Freeman R; Munoz DG; Kremer T; Zago W; Hutten SJ; Adler CH; Serrano GE; Beach TG
J Neuropathol Exp Neurol; 2017 Jan; 76(1):2-15. PubMed ID: 28069931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
